Updated Jul. 1, 2013 at 6:16 p.m.

Premium Lock Tengion closes on $33.6M to continue regenerative medicine R&D

Published: 2013-07-01 18:11:00
Updated: 2013-07-01 18:16:59

Tengion Tengion

Regenerative medicine firm Tengion (OTC:TNGN) has found a way to generate something that has been in short supply for the company: the funding needed to continue R&D work and clinical trials on novel technology for regenerating human tissue....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders